Brain Mechanisms of Reducing Polysubstance Use

May 1, 2026 updated by: Arizona State University

Brain Mechanisms of Reducing Polysubstance Use Following a Novel Body-mind Intervention 2

The proposed study will test whether neurofeedback (NF) could optimize integrative body-mind training (IBMT) practice.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

The proposed study will test whether real-time NF could optimize IBMT practice and improve effects in reducing polysubstance use through targeting self-control networks in the brain.

Study Type

Interventional

Enrollment (Estimated)

35

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Arizona
      • Phoenix, Arizona, United States, 85004
        • Recruiting
        • YiYuan Tang
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • At least 18 years old
  • Free of any psychiatric diagnoses or medication (besides a substance use disorder (SUD) to alcohol, tobacco, or cannabis)
  • In the past month, at least 4 episodes of heavy episodic drinking; at least 3 occasions of cannabis use; and daily cigarette use for at least the past month
  • Normal or corrected-to-normal vision
  • Written informed consent
  • No previous meditation or NF experiences

Exclusion Criteria:

  • Any psychiatric diagnoses other than an SUD
  • Medical disorder(s) that may affect the central nervous system; medications that affect the central and autonomic nervous system; or a positive pregnancy test result (females)
  • Excluding cannabis, evidence of recent (past month) illicit drug use

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: IBMT
An evidence-based preventive intervention - integrative body-mind training (IBMT) has shown positive effects in reducing stress and improving self-control and brain plasticity. It has bodifulness and mindfulness components.
IBMT is an effortless mindfulness technique
Experimental: NF
An evidence-based intervention - NF can not only provide real-time feedback for practice but also target the self-control networks, suggesting the possibility of augmenting IBMT effects via NF.
NF is a mental training technique.
Experimental: IBMT + NF
The combined IBMT and NF also show positive effects in reducing substance use.
IBMT is an effortless mindfulness technique
NF is a mental training technique.
Sham Comparator: Sham NF
Sham NF has the same settings as the active NF but does not have correct parameters of stimulation.
NF is a mental training technique.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intervention effects on brain function using Functional Magnetic Resonance Imaging (fMRI)
Time Frame: The outcome measures are assessed in-person at baseline, 2-4 weeks and 3 months
Brain connectivity changes such as anterior and posterior cingulate cortex measured by fMRI resting state imaging
The outcome measures are assessed in-person at baseline, 2-4 weeks and 3 months
Intervention effects on brain white matter using fMRI
Time Frame: The outcome measures are assessed in-person at baseline, 2-4 weeks and 3 months
Brain white matter changes such as anterior and posterior cingulate cortex measured by fMRI diffusion tensor imaging
The outcome measures are assessed in-person at baseline, 2-4 weeks and 3 months
Intervention effects on brain grey matter using fMRI
Time Frame: The outcome measures are assessed in-person at baseline, 2-4 weeks and 3 months
Brain volume changes such as anterior and posterior cingulate cortex measured by fMRI structural imaging
The outcome measures are assessed in-person at baseline, 2-4 weeks and 3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intervention effects on addiction behavior using substance use questionnaires in PhenX Toolkit
Time Frame: The outcome measures are assessed in-person at baseline, 2-4 weeks and 3 months
Intervention leads to a significant reduction in craving and substance use measured by substance use questionnaires in PhenX Toolkit
The outcome measures are assessed in-person at baseline, 2-4 weeks and 3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2023

Primary Completion (Estimated)

August 31, 2027

Study Completion (Estimated)

August 31, 2027

Study Registration Dates

First Submitted

March 6, 2024

First Submitted That Met QC Criteria

March 15, 2024

First Posted (Actual)

March 22, 2024

Study Record Updates

Last Update Posted (Actual)

May 4, 2026

Last Update Submitted That Met QC Criteria

May 1, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 2024 IBMT NF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Multiple Drug Use

Clinical Trials on IBMT

Subscribe